NCT00052065View on ClinicalTrials.gov

TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

28

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions

Ovarian Neoplasms

Interventions

DRUG

TLK286

Trial Locations (1)

77030

M.D. Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Telik

INDUSTRY